ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
20.41
-0.22 (-1.07%)
At close: May 23, 2025, 4:00 PM
20.40
-0.01 (-0.05%)
After-hours: May 23, 2025, 4:02 PM EDT
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $697.94 million as of May 23, 2025. Its market cap has increased by 20.80% in one year.
Market Cap
697.94M
Enterprise Value
522.00M
1-Year Change
20.80%
Ranking
Category
Stock Price
$20.41
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $697.94M, an increase of 21.33%. That is a compound annual growth rate of 15.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2025 | 705.81M | -21.38% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.76B |
| Johnson & Johnson | 367.77B |
| AbbVie | 321.71B |
| Novo Nordisk | 299.78B |
| UnitedHealth Group | 267.52B |
| Abbott Laboratories | 227.45B |
| Novartis AG | 219.95B |
| AstraZeneca | 215.99B |